Indivior Pharmaceuticals (INDV) Cash & Current Investments (2021 - 2026)
Indivior Pharmaceuticals (INDV) reported Cash & Current Investments of $222 million for Q2 2026, down 56.5% from $510 million a year earlier but up 26.9% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Cash & Current Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, Indivior Pharmaceuticals posted Cash & Current Investments of $195 million, down 39.1% from FY2024.
- Cash & Current Investments has declined for four consecutive years, with a four-year compound annual growth rate of -35.1% (FY2021 to FY2025).
- By year, Cash & Current Investments came in at $320 million in FY2024 (-22.0%), $410 million in FY2023 (-54.1%), $893 million in FY2022 (-19.0%) and $1.1 billion in FY2021.
- Five-year quarterly Cash & Current Investments spans a low of $175 million in Q1 2026 and a high of $1.1 billion in Q4 2021.
- Year over year, Cash & Current Investments has now declined in each of the last three quarters, with an average decline of 42.6% over the last four quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $175 million (Q1 2026), $195 million (Q4 2025) and $445 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Indivior Pharmaceuticals | 4.21 Bn | 3.18 Bn | 294.00 Mn | 222.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 222.00 Mn |
| Mar 31, 2026 | 175.00 Mn |
| Dec 31, 2025 | 195.00 Mn |
| Sep 30, 2025 | 445.00 Mn |
| Jun 30, 2025 | 510.00 Mn |
| Mar 31, 2025 | 373.00 Mn |
| Dec 31, 2024 | 320.00 Mn |
| Dec 31, 2023 | 410.00 Mn |
| Dec 31, 2022 | 893.00 Mn |
| Dec 31, 2021 | 1.10 Bn |
API Access
Indivior Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();